At a Glance
Dosage
Only in 25D-NBOMe
sublingual
| Level | Dose |
|---|---|
| Threshold | 300 µg |
| Light | 300–800 µg |
| Common | 800–1000 µg |
| Strong | 1000–1200 µg |
| Heavy | 1200 µg |
Only in DOI
oral
| Level | Dose |
|---|---|
| Threshold | 0.5 mg |
| Light | 0.5–1 mg |
| Common | 1–2 mg |
| Strong |
Duration
Only in 25D-NBOMe
sublingual
Total: 4 hrs – 6 hrsPeak
Offset
Afterglow
Onset20 min – 40 min
Come Up12 min – 30 min
Peak1 hrs – 2 hrs
Offset1 hrs – 2 hrs
Effects
Safety
Interaction: 25D-NBOMe + DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
25D-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
DOI — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25D-NBOMe and DOI?
25D-NBOMe is classified as a Psychedelic (Substituted phenethylamines) while DOI is classified as a Psychedelic (Substituted amphetamines). They share 46 effects in common, with 20 effects unique to 25D-NBOMe and 20 unique to DOI.
Is it safe to combine 25D-NBOMe and DOI?
There is no direct interaction data available for combining 25D-NBOMe and DOI. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 25D-NBOMe or DOI?
25D-NBOMe and DOI are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.